Medication info
Hyniz Olmesartan Medoxomil Tablets

Hyniz Olmesartan Medoxomil Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Hyunus Meditech Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201503641 · Approved 2015.06.08 · Insurance code 670400970

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while the patient's condition is closely monitored. 2. Elderly patients No dose adjustment is required when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients, although a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use.
Child dose
5. Children The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Hyunus Meditech Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension to help stabilize blood pressure. It helps control blood pressure by expanding blood vessels or reducing the burden on the heart. By continuing to take this medication, it stabilizes blood pressure and contributes to the prevention of cardiovascular complications. Appropriate dosage adjustments may be necessary based on the patient's condition, and it should be used under the guidance of a physician. Through the treatment of essential hypertension, it reduces the risk of serious conditions such as heart attacks and strokes.

How to take

Adult dose

1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while the patient's condition is closely monitored. 2. Elderly patients No dose adjustment is required when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients, although a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use.

Child dose

5. Children The safety and efficacy in children have not been established.

Precautions

This medication can cause severe harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to this drug or any of its components, pregnant or lactating women, patients on renal dialysis, patients with severe liver dysfunction, patients with biliary obstruction, and those with genetic issues such as lactose intolerance should not take this medication. In patients with reduced blood volume or sodium, hypotension may occur, so conditions should be checked before taking the drug, and hypotension symptoms should be closely monitored during use. Patients with impaired kidney function or kidney transplant recipients should regularly check potassium and creatinine levels through blood tests, and it is not recommended for patients with severe renal impairment. Due to the risk of hyperkalemia, particularly in patients with heart failure or renal impairment, serum potassium levels should be monitored closely. This drug has a blood pressure-lowering effect, so dizziness may occur; it is advisable to avoid dangerous activities such as operating machinery or driving while taking it. During the use of this medication, liver function and blood pressure should be regularly checked, and if symptoms such as chronic diarrhea or abdominal pain occur, medical consultation should be sought immediately. Caution is needed when taken with other antihypertensives, potassium-sparing diuretics, or potassium supplements, as potassium levels may increase. When taken with lithium, blood lithium levels may increase, potentially leading to toxicity, and such co-administration is not recommended. Co-administration with non-steroidal anti-inflammatory drugs may worsen renal function, so it is necessary to maintain adequate hydration and monitor renal function. If a pregnant woman takes this medication, there is a risk of decreased renal function in the fetus, oligohydramnios, and neonatal death, so it should not be taken during pregnancy, and it is essential to consult a physician if pregnancy is planned or confirmed. Lactating women should be aware that this medication may be passed into breast milk and could cause adverse reactions in infants, so it is advisable to either discontinue breastfeeding or stop the medication. The safety and efficacy for children have not been established, so it is not advised for pediatric use. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought for appropriate treatment. There is no evidence of carcinogenic or genotoxicity after long-term use of this medication, but if abnormal symptoms occur during use, consult a physician immediately.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increase in creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • indigestion
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial swelling
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • asthma
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture and kept at room temperature between 1 to 25 degrees Celsius. Proper storage can maintain the efficacy of the medication and prevent degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.